Abstract:We have previously demonstrated that human peripheral blood low density mononuclear cells cultured in granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 develop into dendritic cells (DCs) that are extremely efficient in presenting soluble antigens to T cells. To identify the mechanisms responsible for efficient antigen capture, we studied the endocytic capacity of DCs using fluorescein isothiocyanate-dextran, horseradish peroxidase, and lucifer yellow. We found that DCs use two distinct mechanisms for antigen capture. The first is a high level of fluid phase uptake via macropinocytosis. In contrast to what has been found with other cell types, macropinocytosis in DCs is constitutive and allows continuous internalization of large volumes of fluid. The second mechanism of capture is mediated via the mannose receptor (MR), which is expressed at high levels on DCs. At low ligand concentrations, the MR can deliver a large number of ligands to the cell in successive rounds. Thus, while macropinocytosis endows DCs with a high capacity, nonsaturable mechanism for capture of any soluble antigen, the MR gives an extra capacity for antigen capture with some degree of selectivity for non-self molecules. In addition to their high endocytic capacity, DCs from GM-CSF + IL-4-dependent cultures are characterized by the presence of a large intracellular compartment that contains high levels of class II molecules, cathepsin D, and lysosomal- associated membrane protein-1, and is rapidly accessible to endocytic markers. We investigated whether the capacity of DCs to capture and process antigen could be modulated by exogenous stimuli. We found that DCs respond to tumor necrosis factor alpha, CD40 ligand, IL-1, and lipopolysaccharide with a coordinate series of changes that include downregulation of macropinocytosis and Fc receptors, disappearance of the class II compartment, and upregulation of adhesion and costimulatory molecules. These changes occur within 1-2 d and are irreversible, since neither pinocytosis nor the class II compartment are recovered when the maturation-inducing stimulus is removed. The specificity of the MR and the capacity to respond to inflammatory stimuli maximize the capacity of DCs to present infectious non-self antigens to T cells.

CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells

Transcriptional Programming of Dendritic Cells for Enhanced MHC Class II Antigen Presentation

MARCH9‐mediated Ubiquitination Regulates MHC I Export from the TGN

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?

Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System

Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells

Identification of the Interaction Between CD9 and Immune Cells, Immune Factors

Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells

Toll-like receptor 9 signaling antagonizes B cell antigen capture, processing and presentation resulting in a failure to activate helper T cells

Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes

DEC-205 As a Marker of Dendritic Cells with Regulatory Effects on CD8 T Cell Responses.

MHC cross-dressing in antigen presentation

The dendritic cell receptor Clec9A: receptor regulation and immune modulation

The complement regulator CD55 modulates TLR9 signaling and supports survival in marginal zone B cells

CD209 activation promotes survival of lymphoblastic human B cells